Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells

被引:106
作者
Häcker, H
Mischak, H
Häcker, G
Eser, S
Prenzel, N
Ullrich, A
Wagner, H
机构
[1] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany
[2] Med Hsch Hannover, Dept Nephrol, D-30625 Hannover, Germany
[3] Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany
关键词
CpG-DNA; IL-12; innate immunity; MAP kinase; TNF;
D O I
10.1093/emboj/18.24.6973
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of antigen-presenting cells (APCs) by invariant constituents of pathogens such as lipopolysaccharide (LPS) or bacterial DNA (CpG-DNA) initiates immune responses. We have analyzed the mitogen-activated protein kinase (MAPK) pathways triggered by CpG-DNA and their significance for cytokine production in two subsets of APCs, i.e. macrophages and dendritic cells (DCs). We found that CpG-DNA induced extracellular signal-regulated kinase (ERK) activity in macrophages in a classic MEK-dependent way. This pathway up-regulated tumor necrosis factor production but down-regulated interleukin (IL)-12 production. However, in DCs, which produce large amounts of IL-12, CpG-DNA and LPS failed to induce ERK activity. Consistent with a specific negative regulatory role for ERK in macrophages, chemical activation of this pathway in DCs suppressed CpG-DNA-induced IL-12 production. Overall, these results imply that differential activation of MAP kinase pathways is a basic mechanism by which distinct subsets of innate immune cells regulate their effector functions.
引用
收藏
页码:6973 / 6982
页数:10
相关论文
共 62 条
  • [41] PRICHETT W, 1995, J INFLAMM, V45, P97
  • [42] Relative contribution of transcription and translation to the induction of tumor necrosis factor-α by lipopolysaccharide
    Raabe, T
    Bukrinsky, M
    Currie, RA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) : 974 - 980
  • [43] Dendritic cell survival and maturation are regulated by different signaling pathways
    Rescigno, M
    Martino, M
    Sutherland, CL
    Gold, MR
    Ricciardi-Castagnoli, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) : 2175 - 2180
  • [44] Sanghera JS, 1996, J IMMUNOL, V156, P4457
  • [45] ACTIVATED T-CELLS INDUCED INTERLEUKIN-12 PRODUCTION BY MONOCYTES VIA CD40-CD40 LIGAND INTERACTION
    SHU, U
    KINIWA, M
    WU, CY
    MALISZEWSKI, C
    VEZZIO, N
    HAKIMI, J
    GATELY, M
    DELESPESSE, G
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (04) : 1125 - 1128
  • [46] FLT3: Receptor and ligand. Biology and potential clinical application
    Shurin, MR
    Esche, C
    Lotze, MT
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 1998, 9 (01) : 37 - 48
  • [47] T-cell-independent granuloma formation in response to Mycobacterium avium:: role of tumour necrosis factor-α and interferon-γ
    Smith, D
    Hänsch, H
    Bancroft, G
    Ehlers, S
    [J]. IMMUNOLOGY, 1997, 92 (04) : 413 - 421
  • [48] In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas
    Sousa, CRE
    Hieny, S
    SchartonKersten, T
    Jankovic, D
    Charest, H
    Germain, RN
    Sher, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) : 1819 - 1829
  • [49] Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO
  • [50] 2-8